Hypertension is the major risk factor for premature cardiovascular disease, morbidity and mortality. It is the leading cause of death and disability globally, contributing to cardiovascular and renal diseases, including stroke, heart failure, coronary heart disease, and chronic kidney disease. We sought to determine the transcriptional changes that occur in cardiac endothelial cells secondary to hypertension, using ribosomal profiling of mice expressing the ribosomal protein Rpl22 tagged with the hemagglutinin (HA) epitope under control of Tie2-Cre (Tie2-Cre:RiboTag mice). Immunoprecipitation of HA-Rpl22 from heart tissue isolated from Tie2-Cre:RiboTag mice resulted in an approximate 10-fold enrichment of endothelial genes (Pecam-1, VE-cadherin) relative to genes highly expressed in cardiomyocytes (Tnnt2, Fabp3) as assessed by RT-PCR. Subsequently, Tie2-Cre:RiboTag mice were implanted with osmotic pumps delivering saline or angiotensin II (1000ng/kg/min) for 4 weeks. Angiotensin II infusion significantly increased blood pressure (p<0.0001, n=7-8) resulting in an increased heart to body weight ratio (6.07 ± 0.48 vs 8.14 ± 0.73; p<0.05, n=7-8). Transcriptomes from Tie2-Cre positive cells within the heart were isolated using Ribotag ribosomal immunoprecipitation and RNA-seq was performed. Five hundred and eighty seven differentially expressed genes were detected (fold change >1.5, p<0.05, n=3), representing pathways such as extracellular matrix metabolism, angiogenesis and fatty acid transport. Analysis of hypertension associated gene expression in endothelial cells across different organs may reveal the mechanism of hypertension-associated diseases.